Procit faces safety questions; DEA rule on eRx for controlled drugs challenged;

> Johnson & Johnson's Procrit anemia drug is facing FDA scrutiny now that research data has emerged suggesting patients taking it were more likely to die than with a placebo. FiercePharma

> A New York-based group has issued a set of recommendations this week that take on what may be one of the biggest problems RHIOs face--setting uniform standards for getting consent for patient data sharing. FierceHealthIT

> U.K. men afraid to discuss a small, very embarrassing problem with their doctors will now be able to get their prescription online. FiercePharma

> One of the nation's largest and most influential health IT groups is slamming Rep. Pete Stark's bill intended to help subsidize and promote the use of health IT. FierceHealthIT

And Finally... Hey, give the guy a break--his job is very stressful. Article